Css LLC Cerevel Therapeutics Holdings, Inc. Call Options Transaction History

Css LLC

  • $1.01 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
SELL
$40.88 - $43.27 $163,520 - $173,080
-4,000 Reduced 66.67%
2,000 $84,000
Q4 2023

Feb 14, 2024
BUY
$20.27 - $42.44 $121,620 - $254,640
6,000 New
6,000 $254,000
Q3 2021

Nov 15, 2021
SELL
$21.26 - $38.85 $199,844 - $365,190
-9,400 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$12.56 - $29.69 $118,064 - $279,086
9,400 New
9,400 $241,000

Others Institutions Holding CERE

# of Institutions
231
Shares Held
154M
Call Options Held
2.19M
Put Options Held
3.84M
View Full List

About Cerevel Therapeutics Holdings, Inc.

CERE Quotes by TradingView
  • Ticker CERE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 155,752,000
  • Description
  • Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...
More about CERE
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email